Gentronix
Eleanor joined Gentronix in November 2020 as a trainee Study Director. After 11 months of training and the completion of her PhD in cancer biology and DNA repair, she is now a GLP gene mutation Study Director. Eleanor is also responsible for overseeing all aspects of the mouse lymphoma assay, OECD 490, here at Gentronix.
Gentronix
Gentronix provides services for the development of drugs and other chemicals in the cosmetics and personal care sectors.